DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,984 Cr | ₹2,731 Cr | ₹2,156 Cr | ₹1,793 Cr | ₹2,424 Cr |
What is the latest Sundry Debtors ratio of DIVIS LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹2,984 Cr |
| Mar2025 | ₹2,731 Cr |
| Mar2024 | ₹2,156 Cr |
| Mar2023 | ₹1,793 Cr |
| Mar2022 | ₹2,424 Cr |
How is Sundry Debtors of DIVIS LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,984 Cr | 9.26 | |
| Mar2025 | ₹2,731 Cr | 26.67 | |
| Mar2024 | ₹2,156 Cr | 20.25 | |
| Mar2023 | ₹1,793 Cr | -26.03 | |
| Mar2022 | ₹2,424 Cr | - | |
Compare Sundry Debtors of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹244,791.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
| MANKIND PHARMA | ₹93,967.8 Cr | -5.2% | 1.2% | -4.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1.7% |
0.2% |
39.5% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses